Huang Jane — SEC Form 4 filings
SEC reporting owner CIK 1683913. 12 Form 4 filings on record with FilingPulse; latest filed 2026-06-16.
Transaction summary — filings shown
Covers all 12 filings on record, filed 2024-03-04 to 2026-06-16. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 26.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Prelude Therapeutics Inc (PRLD) | President, CMO | 9 | — | — | 23 |
| Protara Therapeutics, Inc. (TARA) | Director | 3 | — | — | 3 |
Form 4 filings — Huang Jane
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-16 | 4 | Protara Therapeutics, Inc. (TARA) | Grant/award (A): 31,000 (derivative) @ $0 | EDGAR |
| 2025-10-07 | 4 | Prelude Therapeutics Inc (PRLD) | Option exercise (M): 9,375 · Tax withholding (F): 3,355 @ $1.47 · Option exercise (M): 9,375 (derivative) @ $0 | EDGAR |
| 2025-07-08 | 4 | Prelude Therapeutics Inc (PRLD) | Option exercise (M): 9,375 · Tax withholding (F): 3,355 @ $0.79 · Option exercise (M): 9,375 (derivative) @ $0 | EDGAR |
| 2025-06-13 | 4 | Protara Therapeutics, Inc. (TARA) | Grant/award (A): 24,000 (derivative) @ $0 | EDGAR |
| 2025-04-07 | 4 | Prelude Therapeutics Inc (PRLD) | Option exercise (M): 9,375 · Tax withholding (F): 3,355 @ $0.68 · Option exercise (M): 9,375 (derivative) @ $0 | EDGAR |
| 2025-02-05 | 4 | Prelude Therapeutics Inc (PRLD) | Grant/award (A): 200,000 (derivative) @ $0 | EDGAR |
| 2025-01-07 | 4 | Prelude Therapeutics Inc (PRLD) | Option exercise (M): 9,375 · Tax withholding (F): 3,859 @ $1.39 · Option exercise (M): 9,375 (derivative) @ $0 | EDGAR |
| 2024-10-07 | 4 | Prelude Therapeutics Inc (PRLD) | Option exercise (M): 9,375 · Tax withholding (F): 3,349 @ $2 · Option exercise (M): 9,375 (derivative) @ $0 | EDGAR |
| 2024-07-08 | 4 | Prelude Therapeutics Inc (PRLD) | Option exercise (M): 9,375 · Tax withholding (F): 3,347 @ $3.60 · Option exercise (M): 9,375 (derivative) @ $0 | EDGAR |
| 2024-06-10 | 4 | Protara Therapeutics, Inc. (TARA) | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2024-04-08 | 4 | Prelude Therapeutics Inc (PRLD) | Option exercise (M): 9,375 · Tax withholding (F): 3,347 @ $4.74 · Option exercise (M): 9,375 (derivative) @ $0 | EDGAR |
| 2024-03-04 | 4 | Prelude Therapeutics Inc (PRLD) | Grant/award (A): 175,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1683913 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →